Helix BioPharma Corp. (HBPCF)
OTCMKTS
· Delayed Price · Currency is USD
0.450
0.00 (0.00%)
Dec 23, 2024, 4:00 PM EST
Helix BioPharma Cash Flow Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | 2019 - 2015 |
| Net Income | -9.35 | -9.26 | -6.29 | -6.56 | -8.04 | -8.99 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.2 | 0.21 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | - | -0.01 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -1.54 | 0.66 | Upgrade
|
| Stock-Based Compensation | 3.54 | 3.52 | 0.57 | 0.43 | 0.66 | 0.47 | Upgrade
|
| Other Operating Activities | -0.22 | 0.03 | 0 | 0.51 | 0.09 | -0.29 | Upgrade
|
| Change in Accounts Receivable | 0.03 | 0.01 | 0.22 | 0.07 | -0.17 | 0.06 | Upgrade
|
| Change in Accounts Payable | 0.75 | 0.67 | -0.07 | -0.87 | 0.05 | -1.55 | Upgrade
|
| Change in Other Net Operating Assets | 1 | -0.19 | 0.04 | -0.1 | 0.07 | -0.63 | Upgrade
|
| Operating Cash Flow | -4.23 | -5.22 | -5.53 | -6.51 | -9.3 | -10.83 | Upgrade
|
| Capital Expenditures | -0 | -0.01 | -0.01 | - | - | -0.02 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | - | 0.01 | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | 2.02 | 1.72 | Upgrade
|
| Investing Cash Flow | 0.01 | -0.01 | -0.01 | - | 2.02 | 1.7 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 3.16 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -2.06 | - | -0.16 | -0.15 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -2.06 | - | 3 | -0.15 | Upgrade
|
| Issuance of Common Stock | 2.82 | 5.51 | 5.63 | 6.21 | 3.56 | 7.73 | Upgrade
|
| Other Financing Activities | - | - | -0.48 | - | - | 5.52 | Upgrade
|
| Financing Cash Flow | 2.82 | 5.51 | 3.09 | 6.21 | 6.56 | 13.1 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | - | - | -0.01 | 0.05 | 0.06 | Upgrade
|
| Net Cash Flow | -1.41 | 0.27 | -2.44 | -0.31 | -0.67 | 4.03 | Upgrade
|
| Free Cash Flow | -4.23 | -5.23 | -5.54 | -6.51 | -9.3 | -10.84 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.12 | -0.14 | -0.22 | -0.34 | -0.42 | Upgrade
|
| Levered Free Cash Flow | -1.89 | -2.75 | -2.2 | -4.24 | -4.8 | -7.13 | Upgrade
|
| Unlevered Free Cash Flow | -1.89 | -2.74 | -2.19 | -4.23 | -4.79 | -7.12 | Upgrade
|
| Change in Net Working Capital | -0.54 | 0.48 | -1.19 | 0.89 | -0.05 | 2.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.